Literature DB >> 10964920

Functional characterization of a lysosomal sorting motif in the cytoplasmic tail of HLA-DObeta.

A Brunet1, A Samaan, F Deshaies, T J Kindt, J Thibodeau.   

Abstract

HLA-DO is an intracellular non-classical class II major histocompatibility complex molecule expressed in the endocytic pathway of B lymphocytes, which regulates the loading of antigenic peptides onto classical class II molecules such as HLA-DR. The activity of HLA-DO is mediated through its interaction with the peptide editor HLA-DM. Here, our results demonstrate that although HLA-DO is absolutely dependent on its association with DM to egress the endoplasmic reticulum, the cytoplasmic portion of its beta chain encodes a functional lysosomal sorting signal. By confocal microscopy and flow cytometry analysis, we show that reporter transmembrane molecules fused to the cytoplasmic tail of HLA-DObeta accumulated in Lamp-1(+) vesicles of transfected HeLa cells. Mutagenesis of a leucine-leucine motif abrogated lysosomal accumulation and resulted in cell surface redistribution of reporter molecules. Finally, we show that mutation of the di-leucine sequence in DObeta did not alter its lysosomal sorting when associated with DM molecules. Taken together, these results demonstrate that lysosomal expression of the DO-DM complex is mediated primarily by the tyrosine-based motif of HLA-DM and suggest that the DObeta-encoded motif is involved in the fine-tuning of the intracellular sorting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964920     DOI: 10.1074/jbc.M005112200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.

Authors:  Andrés Finzi; Alexandre Brunet; Yong Xiao; Jacques Thibodeau; Eric A Cohen
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM.

Authors:  Francis Deshaies; Alexandre Brunet; Djibril A Diallo; Lisa K Denzin; Angela Samaan; Jacques Thibodeau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

Review 3.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

4.  Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DObeta.

Authors:  Francis Deshaies; Djibril A Diallo; Jean-Simon Fortin; Helen M O'Rourke; Abdul Mohammad Pezeshki; Angélique Bellemare-Pelletier; Nicola Raby; Nathalie Bédard; Alexandre Brunet; Lisa K Denzin; Jacques Thibodeau
Journal:  Immunology       Date:  2008-11-14       Impact factor: 7.397

5.  Major histocompatibility complex class-II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane.

Authors:  Andrés Finzi; Mira Perlman; Marie-Claude Bourgeois-Daigneault; Jacques Thibodeau; Éric A Cohen
Journal:  Cell Microbiol       Date:  2012-12-12       Impact factor: 3.715

6.  A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule.

Authors:  Nobuo Watanabe; Yusuke Suzuki; Takahisa Yonezu; Yuki Nakagawa; Takashi Shiina; Noriaki Hirayama; Sadaki Inokuchi; Shigeaki Inoue
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

7.  Ubiquitination of HLA-DO by MARCH family E3 ligases.

Authors:  Martin Jahnke; John Trowsdale; Adrian P Kelly
Journal:  Eur J Immunol       Date:  2013-03-11       Impact factor: 5.532

8.  Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development.

Authors:  Xinjian Chen; Oskar Laur; Taku Kambayashi; Shiyong Li; Robert A Bray; Dominique A Weber; Lars Karlsson; Peter E Jensen
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.